Mylan launches Tecfidera generic amid Biogen battle
20-08-2020
English appeals court refuses Neurim injunction for insomnia drug
26-06-2020
Mylan scores multiple sclerosis patent win over Biogen
23-06-2020
ricochet64 / Shutterstock.com
The Federal Court of Australia has upheld a patent victory for Indian generic manufacturer Sun Pharma over Mylan in a dispute over cholesterol drug fenofibrate.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Mylan, Federal Court of Australia, Sun Pharma, patent, infringement, generics, cholesterol, fenofibrate
